The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study

Open Access

Peer-reviewed

Research Article

Cheuk-Chun Szeto ,

* E-mail: ccszeto@cuhk.edu.hk

Affiliation Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
⨯
Bonnie Ching-Ha Kwan,

Affiliation Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
⨯
Kai-Ming Chow,

Affiliation Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
⨯
Chi-Bon Leung,

Affiliation Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
⨯
Philip Kam-Tao Li

Affiliation Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
⨯

Reader Comments (0)

ACE inhibitor therapy
Is the Subject Area "ACE inhibitor therapy" applicable to this article?

Thanks for your feedback.
Proteinuria
Is the Subject Area "Proteinuria" applicable to this article?

Thanks for your feedback.
Blood pressure
Is the Subject Area "Blood pressure" applicable to this article?

Thanks for your feedback.
Renal system
Is the Subject Area "Renal system" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
ACE inhibitors
Is the Subject Area "ACE inhibitors" applicable to this article?

Thanks for your feedback.
Glomerular filtration rate
Is the Subject Area "Glomerular filtration rate" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.